KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 131 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,990,000 | -27.2% | 585,406 | -19.5% | 0.00% | -50.0% |
| Q2 2018 | $2,734,000 | -28.9% | 727,124 | -22.7% | 0.00% | -20.0% |
| Q1 2018 | $3,847,000 | -62.5% | 940,589 | -34.9% | 0.01% | -68.8% |
| Q3 2017 | $10,257,000 | -23.6% | 1,444,625 | -22.2% | 0.02% | -33.3% |
| Q2 2017 | $13,418,000 | +70.9% | 1,855,839 | +45.6% | 0.02% | +71.4% |
| Q1 2017 | $7,850,000 | +56.3% | 1,274,420 | +48.7% | 0.01% | +27.3% |
| Q4 2016 | $5,023,000 | +266.9% | 857,234 | +232.6% | 0.01% | +450.0% |
| Q3 2016 | $1,369,000 | -78.7% | 257,730 | -73.5% | 0.00% | -86.7% |
| Q2 2016 | $6,427,000 | +345.4% | 970,804 | +214.1% | 0.02% | +275.0% |
| Q1 2016 | $1,443,000 | -69.6% | 309,047 | -67.2% | 0.00% | -60.0% |
| Q4 2015 | $4,754,000 | +3320.1% | 941,334 | +2282.7% | 0.01% | – |
| Q3 2015 | $139,000 | -97.8% | 39,507 | -93.8% | 0.00% | -100.0% |
| Q2 2015 | $6,402,000 | +133.1% | 641,448 | +197.2% | 0.01% | +140.0% |
| Q1 2015 | $2,747,000 | +197.0% | 215,802 | +230.3% | 0.01% | +150.0% |
| Q4 2014 | $925,000 | +51.9% | 65,341 | +65.1% | 0.00% | 0.0% |
| Q2 2014 | $609,000 | +87.4% | 39,565 | +107.6% | 0.00% | +100.0% |
| Q1 2014 | $325,000 | -89.0% | 19,056 | -91.6% | 0.00% | -88.9% |
| Q4 2013 | $2,948,000 | -23.2% | 227,670 | -40.1% | 0.01% | -25.0% |
| Q3 2013 | $3,838,000 | -54.0% | 380,363 | -65.9% | 0.01% | -53.8% |
| Q2 2013 | $8,337,000 | – | 1,116,014 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |